Evidence map›Paper›PMID 42813252›Full record

ArticleCirculation. Genomic and precision medicine2026

Homozygous TNNC1-A8V Causes Impaired Diastolic Function and Restrictive Cardiomyopathy in Children and Mice.

Paula Nieto Morales, Enya Dewars, Amanda M Mascarenhas, Mary Silzer, Minu-Tshyeto Bidzimou, Bo Sun, Brittany Balint, Sara Gregory, Michael Osei Assibey, Karissa Dieseldorff Jones and 10 more

Abstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Paula Nieto MoralesDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee (P.N.M., A.M.M., M.O.A., K.D.J., S.P.C., J.R.P.).
Enya DewarsDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-8504-8198
Amanda M MascarenhasDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee (P.N.M., A.M.M., M.O.A., K.D.J., S.P.C., J.R.P.).
Mary SilzerDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0009-0004-0735-1169
Minu-Tshyeto BidzimouDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-9388-695X
Bo SunDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-0388-1451
Brittany BalintDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-7520-9509
Sara GregoryDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-2832-7094
Michael Osei AssibeyDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee (P.N.M., A.M.M., M.O.A., K.D.J., S.P.C., J.R.P.).ORCID 0009-0001-0543-6992
Karissa Dieseldorff JonesDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee (P.N.M., A.M.M., M.O.A., K.D.J., S.P.C., J.R.P.).ORCID 0000-0002-9124-6246
Rosemeire Kanashiro-TakeuchiDepartment of Molecular & Cellular Pharmacology, University of Miami Leonard M. Miller, School of Medicine, FL (R.K.-T.).ORCID 0000-0002-7305-9172
Juliana LoresClinical Genetics & Genomic Medicine Unit, Clínica Imbanaco (J.L., M.P., C.E.O.).ORCID 0000-0002-0679-4249
Milena PradaClinical Genetics & Genomic Medicine Unit, Clínica Imbanaco (J.L., M.P., C.E.O.).
Carmen E OcampoClinical Genetics & Genomic Medicine Unit, Clínica Imbanaco (J.L., M.P., C.E.O.).ORCID 0000-0003-0673-7401
Carolyn GlassDepartment of Pathology (C.G.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-8850-9906
P Bryant ChaseDepartment of Biological Science, Florida State University, Tallahassee (P.B.C.).ORCID 0000-0001-9701-561X
Vitold E GalkinDepartment of Biomedical and Translational Sciences, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk (V.E.G.).ORCID 0000-0003-1138-7565
Stephen P ChelkoDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee (P.N.M., A.M.M., M.O.A., K.D.J., S.P.C., J.R.P.).ORCID 0000-0003-1675-5945
Andrew P LandstromDepartment of Pediatrics, Division of Cardiology (E.D., M.S., M.-T.B., B.S., B.B., S.G., A.P.L.), Duke University School of Medicine, Durham, NC.ORCID 0000-0002-1878-9631
Jose Renato PintoDepartment of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee (P.N.M., A.M.M., M.O.A., K.D.J., S.P.C., J.R.P.).ORCID 0000-0001-9092-4976

Funding

The mechanisms of cardiac thin filament regulation in health and disease.R01HL160966 · NHLBI · OLD DOMINION UNIVERSITY · PI CHASE, P. BRYANT, GALKIN, VITOLD · 2022 to 2025
$2.3M
Establishing the role of structural elements in cardiac muscle contractionR01HL179825 · NHLBI · FLORIDA STATE UNIVERSITY · PI Vitold Galkin, Michelle Parvatiyar · 2026 to 2026
$703k
Reversal of Hypertrophic Cardiomyopathy via Conditional Ablation of Cardiac Myosin Light Chain KinaseF31HL137408 · NHLBI · FLORIDA STATE UNIVERSITY · PI DIESELDORFF JONES, KARISSA M · 2017 to 2019
$105k
NHLBI NIH HHS F31 HL137408NHLBI NIH HHS R01 HL160966NHLBI NIH HHS R01 HL179825
6 · The paper itself

Abstract

backgroundPathological variants in

methodsA pediatric proband was identified carrying the TNNC1-A8V variant. Sanger sequencing and cardiac evaluations were performed on several of the proband's family members. A literature search was performed to evaluate the cardiac penetrance of TNNC1-A8V. Additionally, we investigated cardiac contractility in a homozygous A8V mouse model. We assessed left ventricular function in 10- to 12-week-old mice via cardiac catheterization and left ventricular global and segmental myocardial strain analyses. Electrophysiological studies were conducted to evaluate arrhythmic predisposition.

resultsWe report an 8-month-old female homozygous for p.A8V (c.C23T) who presented with bi-atrial enlargement, normal ventricular function, and ventricular tachycardia. Cardiac histology of the proband showed subendocardial vacuolization, endocardial fibrosis, and localized myocardial enhancement. The A8V mouse model showed an elevated end-diastolic pressure-volume relationship, prolonged relaxation time (tau), and impaired ventricular relaxation rate (dP/dt min) compared with controls, consistent with increased myocardial stiffness. Strain analyses further highlighted left ventricular dysfunction and dyssynchrony, and ECG analyses revealed atrial remodeling and enlargement at 10 weeks of age.

conclusionsHomozygous A8V mice recapitulate the severe diastolic dysfunction and early-onset restrictive cardiomyopathy observed in the pediatric proband carrying this pathogenic variant, underscoring the utility of this model for advancing translational research. Identifying myofilament-specific defects opens the door for precision therapies tailored to the underlying molecular disarray.

Indexed as

cardiomyopathiesdeathfibrosismyocardiumprognosis

Identifiers

PMID42813252
PMCPMC13629495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.